Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Consolidated Statements of Changes in Equity

v3.10.0.1
Consolidated Statements of Changes in Equity - USD ($)
$ in Thousands
Share capital
Share premium
Capital reserve from share-based payment transactions
Warrants exercisable into shares
Treasury shares
Accumulated other comprehensive income (loss)
Accumulated deficit
Total
Non-controlling Interests
Total
Balance at Dec. 31, 2014 $ 1,373 $ 72,534 $ 4,317 $ 2,633 $ (970) $ 389 $ (72,723) $ 7,553 $ 419 $ 7,972
Net loss (6,243) (6,243) (266) (6,509)
Remeasurement gain (loss) from defined benefit plans (99) (99) (99)
Adjustment arising from translating financial statements from functional currency to presentation currency (58) (58) (58)
Total comprehensive loss (157) (6,243) (6,400) (266) (6,666)
Issuance of share capital and warrants, net of issue expenses 407 7,330 460 4,314 12,511 12,511
Share-based payments 87 87 22 109
Balance at Dec. 31, 2015 1,780 79,864 4,864 6,947 (970) 232 (78,966) 13,751 175 13,926
Net loss (8,257) (8,257) (136) (8,393)
Remeasurement gain (loss) from defined benefit plans 140 (140)
Adjustment arising from translating financial statements from functional currency to presentation currency 119 119 119
Total comprehensive loss 259 (8,397) (8,138) (136) (8,274)
Share-based payments 3 303 306 3 309
Balance at Dec. 31, 2016 1,783 79,864 5,167 6,947 (970) 491 (87,363) 5,919 42 5,961
Net loss (6,339) (6,339) (94) (6,433)
Adjustment arising from translating financial statements from functional currency to presentation currency 636 636 636
Total comprehensive loss 636 (6,339) (5,703) (94) (5,797)
Issuance of share capital and warrants, net of issue expenses 330 1,993 188 1,868   4,379 4,379
Issuance of share capital 10 85   95 95
Proceeds from sale of subsidiary in previously consolidated subsidiaries (838) 970   132 52 184
Share-based payments 192 192 192
Balance at Dec. 31, 2017 $ 2,123 $ 81,104 $ 5,547 $ 8,815 $ 1,127 $ (93,702) $ 5,014 $ 5,014